
Ali Djalilian
Co-Director, Cornea and External Disease Service · University of Illinois College of Medicine at Chicago
Credentials: · · ·
History
- Present
Cornea and External Disease Service · University of Illinois College of Medicine at Chicago
- Present
Corneal Stem Cell and Tissue Engineering Laboratory · University of Illinois College of Medicine at Chicago
2000–2001- 1999–2000
Research Fellowship in Epithelial Biology: National Eye Institute and National Human Genome Research Institute
- 1995–1996
Research
TFOS DEWS II Diagnostic Methodology report
Review · The Ocular Surface · 2017 · 1,652 citations
Investigative Ophthalmology & Visual Science · 2018 · Last of 8 authors · 230 citations
Current and emerging therapies for corneal neovascularization
Review · The Ocular Surface · 2018 · 168 citations

45 papers

24 papers · 6 as a resident
- EH
23 papers
- ME
21 papers · 2 as a resident
- GY
19 papers · 3 as a resident

14 papers

14 papers · 1 as a resident

13 papers
Grants
- 2026–2030
National Eye Institute · R01
PI · $528K · University of California Los Angeles
- 2011–2029
UIC K12 Independent Clinical Vision Scientist Development Program
National Eye Institute · K12
Contact PI · $2.2M · University of Illinois at Chicago
- 2024–2028
Cell-Derived Therapies for Corneal Nerve Repair: Structural and Functional Mechanisms
National Eye Institute · R01
Contact PI · $2.1M · University of Illinois at Chicago
- 2020–2027
Phase I Study of Mesenchymal Stromal Cell Secretome for Promoting Corneal Regeneration
National Eye Institute · UH3
Contact PI · $1.6M · University of Illinois at Chicago
Clinical trials
- 2025–2026
Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
Principal investigator · Recruiting · Phase 2
University of Illinois at Chicago
- 2024
Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
Principal investigator · Completed · Early phase 1
University of Illinois at Chicago
- 2023–2026
Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells
Principal investigator · Recruiting · Phase 2
University of Illinois at Chicago
- 2021–2023
Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells
Principal investigator · Completed · Phase 1
University of Illinois at Chicago

